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Pat ent s  and R& D 
ex pendi t ure 
Most EPO patent applications submitted by EU businesses 
Figure 1: Patent applications to the European Patent Office (EPO) 
broken down by institutional sector for EU-25, in 2002 
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Source: Eurostat, patent statistics 
Main findings 
‚ Businesses applied for most EPO patents (82.4%). Only 17.6% of 
EPO patent applications are from other institutional sectors. 
‚ A high level of gross domestic expenditure on R&D (GERD) leads in 
most countries to a high number of patent applications to the EPO or 
patents granted by the USPTO. 
‚ The United States, Germany and Japan are worldwide leaders in 
patenting at the European Patent Office (EPO) and at the United 
States Patent and Trademark Office (USPTO). 
‚ The ratio of business enterprise R&D to EPO patent applications in 
the business sector tells us that EU patent applications require less 
research funds than American or Japanese applications.  
‚ Analysis of the results of the Patent Scorecard 2006 reveals that, in 
spite of American leadership in US patenting activity, Europe plays a 
significant role in US patenting in industrial sectors such as 
pharmaceuticals (47%), telecommunications (39%), energy and 
environmental (38%), chemicals (29%), and automotive and 
transportation (27%). ( #  
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 Patent statistics provide important indicators for 
measuring R&D output. Long time series are available 
and data allow cross-country comparison. This 
publication looks more closely at the role of patent 
applications and patents granted as an output of R&D 
expenditure. The link between R&D expenditure and 
patents is not straightforward. R&D expenditure is 
allocated in three areas: basic research, applied 
research, and development. Basic research, in 
particular, generally does not lead directly to 
inventions and patents. Inventions can also be 
protected by licences, trademarks or copyrights.  
There is also a time lag between funds being spent 
and an invention being ready for a patent application. 
Patent procedures take several years and some 
patents are not granted, because they do not fulfil the 
criteria. This also depends on the national research 
structures and on the underlying economic activities. 
Figure 1 shows all patent applications from the EU-25 
to the EPO in 2002 broken down by institutional 
sector. The breakdown distinguishes four sectors: 
BES – business enterprise sector, GOV – government 
sector, HES – higher education sector, and OTH – 
other. The business enterprise sector accounts for by 
far the most patenting activity in the EU-25 with 
82.4%. The government sector comes second with 
13.8%. Other sectors produce very few EPO patent 
applications.  
R&D expenditure and EPO patent applications are correlated 
Figure 2: Patent applications to the EPO per 
million inhabitants and R&D expenditure per 
inhabitant, in 2002 
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Source: Eurostat, R&D statistics and patent statistics 
Figures 2 and 3 correlate patent applications/patents 
granted with R&D expenditure.  
Figure 2 shows patent applications to the EPO per 
million inhabitants and R&D expenditure per 
inhabitant in 2002. The trend line indicates a positive 
correlation between the two indicators. The higher the 
R&D expenditure, the higher the number of patent 
applications produced by a country tends to be. EU 
Member States such as Malta, the Czech Republic 
and Hungary that spent less than EUR 100 per 
inhabitant on R&D produced less than 20 patent 
applications per million inhabitants in 2002. The R&D 
expenditure of Denmark, Finland and Iceland stood at 
more than EUR 800 per inhabitant and the number of 
patent applications per million inhabitants was 181 for 
Iceland, 217 for Denmark and 307 for Finland. As 
Figure 2 reveals, Iceland spent more on R&D per 
inhabitant than Finland, but produced fewer patent 
applications.  
Belgium and the Netherlands provide another 
interesting comparison. With around EUR 500 R&D 
expenditure per inhabitant, both countries allocate the 
same amounts to R&D, but the number of patent 
applications per million inhabitants is 141 and 244 for 
Belgium and the Netherlands respectively. 
Figure 3: Patents granted by the USPTO per 
million inhabitants and R&D expenditure per 
inhabitant, in 1999 
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Source: Eurostat, R&D statistics and patent statistics 
Figure 3 shows patents granted by the United States 
Patent and Trademark Office (USPTO) per million 
inhabitants and R&D expenditure per inhabitant in 
1999. As the trend line shows, the two indicators are 
also correlated. The United Kingdom, Belgium, Austria 
and Finland are on this trend line. Countries below the 
trend line, such as Italy, Ireland, the Netherlands and 
Germany, produced more patents in relation to GERD 
spent. Countries above the trend line, such as 
Norway, France, Denmark and Iceland, produced 
fewer patents than expected from their R&D 
expenditure. 
 Business enterprise sector dominates patenting in the EU and the US
Figure 4: Patent applications to the EPO by 
institutional sector for the 20 leading countries 
worldwide and total number, 2002 
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Source: Eurostat, patent statistics 
Figure 4 shows the 20 leading countries worldwide in 
number of patent applications to the EPO in 2002. 
The United States leads by far with 46 819 patent 
applications, followed by Germany and Japan with 
24 514 and 24 494 patent applications respectively. 
While the second and third-placed countries are 
almost level, the numbers fall sharply thereafter. 
Eleven of the 20 worldwide leaders are EU-25 
Member States. Along with Japan, there are three 
other Asian countries among the 20 best performing 
countries: South Korea (8), China (15) and India (20). 
The business enterprise sector is the most active in 
EPO patenting. This general statement conceals 
some national differences. China is the only country 
among the 20 countries shown in which the business 
enterprise sector accounts for less than 55%, whereas 
in many other countries the BES accounts for 70% or 
more. For EU Member States the BES share ranges 
from 63% in Spain to 92% in Finland, compared with 
82% in the United States. 
The government sector is always the second-largest 
sector in EPO patenting. China has the highest 
percentage with more than 36% of Chinese patent 
applications coming from the government sector. This 
sector is also strong (around 30%) in Spain and 
France compared with the EU-25 average of 13.8%. 
The government share of American patent 
applications is 10.8%. 
The patent output of the other institutional sectors is in 
general rather small. One exception is the higher 
education sector in Israel, which is involved in more 
than 7% of all patent applications from that country. 
Figure 5: Patents granted by the USPTO by 
institutional sector for the 20 countries leading 
worldwide and total number, 1999 
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Source: Eurostat, patent statistics 
The results for patents granted by the USPTO for the 
20 leading countries worldwide in 1999 are quite 
similar.  
Roughly, the same countries are worldwide leaders, 
but the ranking is not the same. For patents granted 
by the USPTO, the United States is the absolute 
leader followed by Japan and Germany. The total 
numbers fall rapidly with the ranking. While 87 103 
USPTO patents granted are American, only 32 177 
are Japanese and 10 622 are German. Among the 20 
leading countries, there are the same eleven EU 
Member States, but the four Asian countries are: 
Japan (2), Taiwan (4), South Korea (5) and Singapore 
(19). 
Most USPTO patents are also granted to enterprises. 
There is one exception: Denmark. 57% of Danish 
patents granted by the USPTO go to the government 
sector.  
In Singapore, close to 7% of successful applications 
to the USPTO come from applicants in the higher 
education sector such as universities. In other 
countries, this sector often produces few patents 
(between 1% and 2% of all USPTO patents granted).
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 Table 6: Total number of patent applications to the EPO as ratio per billion BERD, HERD and GOVERD in 
2002 and total number of patents granted by the USPTO as ratio per billion BERD, HERD and GOVERD in 
1999, EU-25 Member States, candidate countries, JP, RU, US 
Total 
number
Total 
number
EU-25 EU-25 59 756 410 s 342 s 28 s 24 733 211 s 128 s 6 s
EU-15 EU-15 59 074 412 s 346 s 29 s 24 602 213 s 131 s 6 s
Belgium BE 1 452 314 495 83 599 155 147 39
Czech Republic CZ 122 125 203 13 29 54 42 8
Denmark DK 1 167 280 657 r 26 395 77 437 2
Germany DE 24 514 587 251 26 10 622 290 104 4
Estonia EE 10 199 556 0 3 171 149 0
Greece EL 109 : : : 10 32 15 0
Spain ES 1 246 199 353 29 285 78 82 7
France FR 8 556 268 444 16 3 685 158 131 4
Ireland IE 311 232 r 493 58 163 172 395 14
Italy IT 4 747 545 315 15 1 670 251 102 3
Cyprus CY 5 607 60 33 2 231 94 0
Latvia LV 13 112 1 237 20 1 0 121 0
Lithuania LT 10 99 240 0 1 579 0 0
Luxembourg LU 69 : 232 : 36 : : :
Hungary HU 193 351 439 11 52 263 178 20
Malta MT 5 1 305 255 47 3 : : :
Netherlands NL 3 934 773 199 38 1 213 243 116 i 5
Austria AT 1 483 383 965 2 520 : : :
Poland PL 179 277 191 12 21 26 17 2
Portugal PT 49 101 e 63 e 4 e 12 36 22 2
Slovenia SI 103 333 277 33 12 54 43 7
Slovakia SK 41 256 421 13 6 33 89 6
Finland FI 1 593 434 210 7 738 258 106 2
Sweden SE 2 587 : : : 1 391 197 381 1
United Kingdom UK 7 258 279 350 59 3 264 163 143 12
Iceland IS 52 268 f 128 f 4 f 23 219 62 0
Norway NO 610 251 214 1 224 135 101 0
Switzerland CH 2 987 : 3 479 36 1 286 : : :
Bulgaria BG 36 924 362 108 9 294 94 0
Croatia HR 87 267 864 0 7 : : :
Romania RO 30 59 497 30 5 36 60 35
Turkey TR 118 189 535 1 10 11 55 2
Japan JP 24 494 234 98 7 32 178 358 56 4
Russia RU 591 56 341 36 210 106 141 62
United States US 46 819 187 pi 195 pi 54 pi 87 116 393 i 969 i 76 i
USPTO - 1999
number of 
patent 
applications in 
BES as ratio of 
billion BERD
number of 
patent 
applications in 
GOV as ratio of 
billion GOVERD
number of 
patent 
applications in 
HES as ratio of 
billion HERD
number of 
patents in 
BES as ratio 
of billion 
BERD
number of 
patents in GOV 
as ratio of 
billion 
GOVERD
number of 
patents in 
HES as ratio 
of billion 
HERD
EPO - 2002
 
Source: Eurostat, patent statistics
Table 6 shows output/input ratios by institutional 
sector (business enterprise sector, government sector 
and higher education sector) for EPO and USPTO 
data.  
   
Taking the EU-25, enterprises applied in 2002 for 410 
EPO patents per billion BERD input. In comparison, 
the United States produced only 187 patent 
applications per billion BERD. With 234 patent 
applications per billion BERD, the result for Japan was 
better than for the United States, but below the EU 
average. Germany, Italy, the Netherlands and Finland 
achieved higher results than the EU average with 
respectively 587, 545, 773 and 434 EPO patent 
applications per billion BERD. For France and the 
United Kingdom, the output/input ratio was lower than 
the EU average with 268 and 279 EPO patent 
applications per billion BERD respectively.  
For the EU, the results are quite similar for patents 
granted by the USPTO. The countries mentioned 
above with higher results also exceed the EU average 
of 211 patents granted per billion BERD input. Those 
that failed to reach the EU average for the EPO also 
failed to reach the EU average for the USPTO. By 
contrast, the United States does better than the EU 
average with 393 patents granted per billion BERD. 
Japan, with 358 patents granted per billion BERD, 
also beat the EU average, but did not match the US. 
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 This analysis should take into account the “home 
advantage” for R&D funds for the European Union 
and the United States. Countries always spend the 
largest share of their R&D funds in their home 
country, with consequently more patenting at the EPO 
or at the USPTO. 
The output/input ratios for countries with very low 
patenting activity (less than 10 patents per institutional 
sector) could not be interpreted as strictly. 
 
EU patent applications to the EPO are less expensive than US ones 
Figure 7: Average R&D expenditure for a patent application to the EPO in BES, 1992-2002,  
EU-25, US, and JP, in euro 
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Source: Eurostat, patent statistics 
Figure 8: Average R&D expenditure for a patent granted by the USPTO in BES, 1989-1999,  
EU-25, US, and JP, in euro 
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Source: Eurostat, patent statistics 
Figures 7 and 8 illustrate the average R&D 
expenditure per patent application/patent granted in 
the business sector over time for the EU-25, Japan 
and the United States. Whereas Figure 7 is based on 
EPO data for the years 1992 to 2002, Figure 8 uses 
USPTO data for the period 1989 to 1999.  
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An EU patent application to the EPO in 2002 costs on 
average EUR 2.4 million in terms of R&D expenditure. 
The amount seems high, but not all funds spent on 
R&D are used exclusively and directly for patenting 
activities at the EPO or USPTO. Also, no distinction 
can be made between funds used for EPO or USPTO 
patenting. The patents themselves are very different 
depending on the industrial sector. Some patents 
need very little research while others require the work 
of a group of researchers over many years. 
The average US patent application to the EPO in 
2002 costs EUR 5.3 million in terms of R&D 
5 #"
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expenditure whereas Japan spent an average of EUR 
4.3 million on each patent application to the EPO. In 
1994, Japan spent in terms of R&D expenditure close 
to EUR 7 million per patent application but after that 
the amount fell steadily. Since 1999, Japanese EPO 
patent applications have been less expensive than 
those of the US, but they are still more expensive than 
EU applications. The European curve fell from EUR 3 
million in 1989 to nearly EUR 2 million in 1999 and 
finished up in 2002 close to EUR 2.5 million. 
Looking at Figure 8, EU patents granted by the 
USPTO are much more expensive in relation to BERD 
than patents granted by the USPTO for Japan and the 
United States. Whereas an EU patent needed an 
average R&D investment of EUR 4.7 million, only 
EUR 2.8 million and EUR 2.5 million were required 
respectively for a Japanese or an American patent. 
While the average expenditure for patents granted by 
the USPTO from the United States and Japan stood 
at between EUR 2 and 3 million per patent during the 
whole period, EU patents were consistently costlier, at 
between EUR 4 and 5 million.  
 
USPTO requesting more timely and useful 
information from patent applicants 
Proposal would improve patent quality and may bring 
quicker decisions
[Extract] As part of its ongoing efforts to promote 
investment in innovation and spur economic growth, 
the Department of Commerce's U.S. Patent and 
Trademark Office (USPTO) today announced a new 
proposal that would streamline and improve the patent 
application review process. The new proposal would 
encourage patent applicants to provide the USPTO 
the most relevant information related to their 
inventions in the early stages of the review process… 
Source: USPTO, press release 6th July 2006 
 
The Patent Scorecard 2006 
An American company called Intellectual Property 
Intelligence Quotient (ipIQ) specialising in patent 
research, publishes an annual “Patent Scorecard”. 
The 2006 edition of the Patent Scorecard is broken 
down by company, including all US patents held by 
each company across multiple industry sectors. The 
companies chosen are the world’s 2 500 largest 
technology firms. 
Table 9: US patenting activity broken down by 
industrial sector and world region, as a 
percentage of 2 500 of the world’s top technology 
firms, 2005 
 Industrial sector North America Asia Europe
1 Aerospace and defence 81% 2% 17% 
2 Automotive and transportation 29% 44% 27% 
3 Biotechnology 90% - 10% 
4 Chemicals 34% 37% 29% 
5 Consumer electronics 9% 87% 7% 
6 Consumer products 56% 36% 8% 
7 Electronics and instruments 53% 42% 5% 
8 Energy and 
environmental 51% 11% 38% 
9 Food, beverage, and tobacco 46% 25% 29% 
10 Industrial equipment 
and materials 50% 32% 18% 
11 Information technology 42% 57% - 
12 Medical devices 76% 15% 9% 
13 Pharmaceuticals 47% 6% 47% 
14 Semiconductors 40% 48% 12% 
15 Telecommunications 55% 6% 39% 
Source: Eurostat based on ipIQ, Patent Scorecard 2006 
The 2 500 companies are split into 15 industrial 
sectors (see Table 9). As the companies’ activities are 
sometimes very diverse, some companies may be 
part of several industrial sectors. The Patent 
Scorecard 2006 covers data to December 2005. 
For each industrial sector, the same analysis is made. 
ipIQ comments on the overall patenting activity of the 
sector. Then a list shows the Top 10 companies with 
highest level of technology strength (see 
methodological notes) in the sector.  
For example, in the automotive and transportation 
sector, the EU company Bosch ranks fourth in 2005 
after Denso, Delphi Automotive Systems and Honda. 
Bosch was number three in 2004, before Honda. 
A second listing shows several significant movers, 
which are companies that lost or gained several 
places compared with the year before. In the 
pharmaceuticals sector, the company Sanofi-Aventis 
moved up three positions from 15th to 12th. 
Looking at US patenting activity at international level, 
American leadership is undeniable in several 
industries such as aerospace and defence, 
biotechnology, and medical devices. Japan leads in 
consumer electronics and, to a lesser extent, in 
information technology. Europe performs as well as 
the United States in pharmaceuticals. Europe’s share 
of the automotive and transportation, chemicals, and 
telecommunications sectors is nearly as large as that 
of the US. 
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 Es s en t i a l  i n f o r m at i o n  – Met h o d o l o g i c al  n o t es  
1. Gross domestic expenditure on R&D 
Gross domestic expenditure on R&D (GERD) is total 
intramural expenditure on R&D performed on the 
national territory during a given period. It includes R&D 
performed within a country and funded from abroad but 
excludes payments made abroad for R&D. 
BERD Business enterprise expenditure on R&D 
GOVERD Government sector expenditure on R&D 
HERD Higher education sector expenditure on 
R&D 
Source: Eurostat, R&D statistics 
2. Patent statistics  
The production of patent statistics at Eurostat was 
reorganised in 2005. This means that the data shown in 
this Statistics in Focus publication and on the Eurostat 
webpage are no longer entirely comparable with the 
data published previously.  
In 2005, only one single raw database
7 #"
 
 – mainly 
compiled based on input from the European Patent 
Office (EPO), the US Patent and Trademark Office 
(USPTO) and the Japanese Patent Office (JPO) – was 
used to produce an extended set of tables and 
indicators on the Eurostat webpage. This will also be 
done in the years to come. The aggregated patent 
statistics are produced on a raw data set delivered by 
the OECD. This raw data set will be replaced by 
PATSTAT for the next data productions.   
Eurostat continues to produce the patent statistics 
(source: Eurostat/EPO) it started some years ago. 
However, these statistics are now produced using the 
priority year of the application, and not the year of filing 
as previously. The data values are, however, similar. 
These data are in general less extensive than the data 
released by Eurostat. This is because all PCT 
applications filed to the EPO (i.e. applications made in 
accordance with the procedure under the Patent 
Cooperation Treaty) are taken into consideration by 
Eurostat whereas the OECD datasets do so only in part. 
Eurostat has implemented the changes described 
above as only one single data source is now used (as 
described above) and as the data produced provide a 
better reflection of the innovation and R&D performance 
of an economy.  
For all further details, please see the Eurostat metadata 
on patent statistics posted on the webpage.  
Counting patents with multiple inventors 
Where a patent lists several inventors from different 
countries, the respective contributions from each 
country are taken into account. This is done in order to 
eliminate multiple counting of such patents. For 
example, a patent that lists the inventors as 1 French, 1 
American and 2 German residents will be counted as 
1/4 of a patent for France, 1/4 for the USA and ½ for 
Germany.  
Breakdown by institutional sector 
It should be mentioned that the decision to classify an 
applicant in an institutional sector is not always 
straightforward. Many patent applications are made in 
collaboration between institutions in two or more 
sectors. For instance, a scientific project can be 
financed by the business enterprise sector but executed 
by a state-owned University. 
Source: Eurostat, patent statistics 
3. Patent Scorecard 2006 
From a methodological point of view, data are not 
comparable to those shown in the main part of the 
publication. (On the one hand, data sources are 
different and on the other hand, the Scorecard does not 
give any detailed information on the methodology used 
for the breakdown by industry and for the geographical 
aggregation.) 
For the industry top 10 and the significant movers, five 
indicators are calculated for 2005 and as a 5-year 
average. These indicators are technology strength, the 
current impact index (CII), science linkage (SL), the 
technology cycle time (TCT) and the patent count. The 
rankings are based on technology strength. 
Technological strength provides an overall assessment 
of a company’s intellectual property and innovation 
strength. Calculations represent all US patents filed as 
of December 2005. 
Source: IPIQ, Patent Scorecard 2006 
Symbols 
:  not available 
e estimated value 
f forecast 
i more information in explanatory notes 
p provisional value 
s Eurostat estimate 
r  revised value 
Country codes 
AU Australia 
CA Canada 
CN China 
IL Israel 
IN India 
KR South Korea 
SG Singapore 
Data presented in this Statistics in Focus reflect 
availability in Eurostat’s reference database as at June 
2006. 
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Data: EUROSTAT Website/Home page/Science and technology/Data
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Journalists can contact the media support 
service: 
Bech Building Office A4/125  
L - 2920 Luxembourg 
 
Tel. (352) 4301 33408 
Fax  (352) 4301 35349 
 
E-mail:  eurostat-mediasupport@ec.europa.eu  
European Statistical Data Support: 
Eurostat set up with the members of the ‘European 
statistical system’ a network of support centres, which 
will exist in nearly all Member States as well as in some 
EFTA countries. 
Their mission is to provide help and guidance to Internet 
users of European statistical data. 
Contact details for this support network can be found on 
our Internet site: http://ec.europa.eu/eurostat/
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